title: Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
abstract: We have discovered that native, neuronal expression of alpha-synuclein (Asyn) inhibits viral infection, injury, and disease in the central nervous system (CNS). Enveloped RNA viruses, such as West Nile virus (WNV), invade the CNS and cause encephalitis, yet little is known about the innate neuron-specific inhibitors of viral infections in the CNS. Following WNV infection of primary neurons, we found that Asyn protein expression is increased. The infectious titer of WNV and Venezuelan equine encephalitis virus (VEEV) TC83 in the brains of Asyn-knockout mice exhibited a mean increase of 10(4.5) infectious viral particles compared to the titers in wild-type and heterozygote littermates. Asyn-knockout mice also exhibited significantly increased virus-induced mortality compared to Asyn heterozygote or homozygote control mice. Virus-induced Asyn localized to perinuclear, neuronal regions expressing viral envelope protein and the endoplasmic reticulum (ER)-associated trafficking protein Rab1. In Asyn-knockout primary neuronal cultures, the levels of expression of ER signaling pathways, known to support WNV replication, were significantly elevated before and during viral infection compared to those in Asyn-expressing primary neuronal cultures. We propose a model in which virus-induced Asyn localizes to ER-derived membranes, modulates virus-induced ER stress signaling, and inhibits viral replication, growth, and injury in the CNS. These data provide a novel and important functional role for the expression of native alpha-synuclein, a protein that is closely associated with the development of Parkinson's disease.
  
  
  OBJECTIVE
  Neuroinvasive viruses such as West Nile virus are able to infect neurons and cause severe disease, such as encephalitis, or infection of brain tissue. Following viral infection in the central nervous system, only select neurons are infected, implying that neurons exhibit innate resistance to viral infections. We discovered that native neuronal expression of alpha-synuclein inhibited viral infection in the central nervous system. When the gene for alpha-synuclein was deleted, mice exhibited significantly decreased survival, markedly increased viral growth in the brain, and evidence of increased neuron injury. Virus-induced alpha-synuclein localized to intracellular neuron membranes, and in the absence of alpha-synuclein expression, specific endoplasmic reticulum stress signaling events were significantly increased. We describe a new neuron-specific inhibitor of viral infections in the central nervous system. Given the importance of alpha-synuclein as a cause of Parkinson's disease, these data also ascribe a novel functional role for the native expression of alpha-synuclein in the CNS.
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Erica L
authors.initials: EL
authors.lastname: Beatman
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Aaron
authors.initials: A
authors.lastname: Massey
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Katherine D
authors.initials: KD
authors.lastname: Shives
authors.affiliation: Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Kristina S
authors.initials: KS
authors.lastname: Burrack
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Mastooreh
authors.initials: M
authors.lastname: Chamanian
authors.affiliation: Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Morrison
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA david.beckham@ucdenver.edu.
authors.forename: J David
authors.initials: JD
authors.lastname: Beckham
mesh_terms: D000818:Animals; D001921:Brain / Q000276:immunology* / Q000821:virology; D002478:Cells, Cultured; D004666:Encephalitis Virus, Venezuelan Equine / Q000276:immunology* / Q000302:isolation & purification; D005260:Female; D015870:Gene Expression; D007113:Immunity, Innate; D008297:Male; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009474:Neurons / Q000276:immunology / Q000821:virology; D012327:RNA Virus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D016019:Survival Analysis; D014902:West Nile virus / Q000276:immunology* / Q000302:isolation & purification; D051844:alpha-Synuclein / Q000096:biosynthesis*
chemical_list: D051844:alpha-Synuclein